Literature DB >> 35546823

TfOH mediated intermolecular electrocyclization for the synthesis of pyrazolines and its application in alkaloid synthesis.

Sesuraj Babiola Annes1, Pothiappan Vairaprakash1, Subburethinam Ramesh1.   

Abstract

TfOH mediated easy access to interesting pyrazolines starting from an aldehyde, phenylhydrazine and styrene has been developed. The scope of this synthetic methodology has been explored by synthesizing various 1,3,5-trisubstituted pyrazolines in very good yields with very high regioselectivity. The origin of regioselectivity has been explained by comparing the stability of possible intermediate carbocations. The synthetic utility of a green solvent has been explored by synthesizing some of pyrazolines in a DES medium. The synthetic application of the present methodology is employed in the synthesis of a pyrazoline alkaloid. This journal is © The Royal Society of Chemistry.

Entities:  

Year:  2018        PMID: 35546823      PMCID: PMC9085413          DOI: 10.1039/c8ra05702h

Source DB:  PubMed          Journal:  RSC Adv        ISSN: 2046-2069            Impact factor:   4.036


Pyrazoles and pyrazolines are known to exhibit interesting biological and photo-physical behaviours. The biological activities of pyrazoles/pyrazolines have been discussed in several reviews.[1-4] A few representative examples of biologically and medicinally important pyrazoles and pyrazolines are given in Fig. 1.[5-7] In particular, considerable interest has been focused on 1,3,5-trisubstituted pyrazoline derivatives due their potential pharmacological activities including (i) antitubercular activity against the H37Rv strain of Mycobacterium,[9] (ii) antiproliferative activity,[8,10] (iii) antibacterial activity,[11-13] (iv) antiobesity effect in an animal model of the potent cannabinoid CB1 receptor antagonist,[14] (v) pre-emergent herbicide activity against various kinds of weeds,[15] and (vi) ACE-inhibitory activity with 0.123 mM IC504.[16] Pyrazoline derivatives show enhanced biological activity compared with their corresponding pyrazoles.[17] In addition, the pyrazoline motif is known to exhibit photo-luminescent behaviour due to intra-molecular charge transfer (ICT) in the excited state and also shows hole transport behaviour.[18-24]
Fig. 1

Representative examples of medicinally important 1,3,5-trisubstituted pyrazolines and pyrazoles.

Various synthetic approaches have been developed to access these biologically important 1,3,5-trisubstituted pyrazoline/pyrazole compounds.[25-28] The most general synthetic approach proceeding via a reaction of 1,3-dicarbonyl compounds with arylhydrazines results in poor regioselectivity.[3,29,30] A synthetic method which employs appropriate chalcones and arylhydrazines has been considered to be the most widely accepted method for accessing pyrazolines, but this method falls behind due to a greater number of synthetic steps involved.[31-34] Recently Wang et al. disclosed a methodology proceeding via a three component [3 + 2] cycloaddition using 20 mol% Cu(OTf)2 at elevated temperature.[35] The development of synthetic methodology to prepare active pharmaceutical ingredients (APIs) would preferably involve (i) high regioselectivity, (ii) diversity in substrates, (iii) the least number of synthetic steps involved and (iv) attaining target compounds, free of metal traces. Hence, a regioselective tandem one-pot intermolecular electrocyclization reaction under metal free condition to access 1,3,5-trisubstituted pyrazolines would be of great importance. In this regard, we are disclosing a general, metal free and green synthetic methodology to access diverse pyrazoline derivatives with various functionalities including –NO2, –OH and aliphatic groups using arylhydrazines, aldehydes and styrenes. We have obtained the corresponding pyrazoline products in very good yields with enhanced regioselectivity. In addition, we have employed this synthetic methodology in the synthesis of a pyrazoline alkaloid (1,5-diphenyl-3-styryl-2-pyrazoline). In our initial studies to attempt metal free conditions, iodine mediated intermolecular electrocyclization of tolualdehyde 1a, phenylhydrazine 2a and styrene 3 was explored (Table 1). The use of a substoichiometric amount of iodine (0.2 equiv.) yielded the corresponding pyrazoline 4a in 25% yield (Table 1, entry 1). Increasing the amount of iodine did not result in considerable enhancement of the yield (Table 1, entries 1–5). Due to it being less hazardous among the screened solvents, acetonitrile was used as a solvent for further screening of other non-metal catalysts including TfOH, PhIOAc, NaI, NBS, CAN, l-proline, CH(OMe)3, TFA, p-TSA and MeSO3H (Table 1, entries 6–13). TfOH was found to be the most effective in mediating electrocyclization and pyrazoline 4a was obtained in 82% yield (Table 1, entry 12). It is presumed that TfOH alone is capable of forming an intermediate carbocation I-1via hydride abstraction from hydrazone by the superacid species TfOH2+ (Scheme 1).[36,37] The use of other solvents such as H2O, DMF, DMSO and ethanol did not result in product formation, as TfOH might be deactivated by these solvents (see ESI, Table S1†).

Optimization of reaction conditions in the synthesis of pyrazoline 4aa

EntryAdditive (equiv.)SolventTime (h)Yieldb (%)
1I2 (0.2)CH3CN2425
2I2 (1.0)CH3CN2434
3I2 (1.0)Toluene2440
4I2 (1.0)H2O2435
5I2 (1.0)EtOAc24Trace
6PhI(OAc)2 (0.2)CH3CN24ND
7NaI (1.0)CH3CN24ND
8NBS (1.0)CH3CN24ND
9CAN (1.0)CH3CN24ND
10 l-Proline (0.3)CH3CN24ND
11CH(OMe)3 (1.0)CH3CN24ND
12 TfOH (1.0) CH 3 CN 7 82
13TFA (1.0)CH3CN24ND
14p-TSA (1.0)CH3CN2418
15MeSO3H (1.0)CH3CN2413

A solution of tolualdehyde 1a (1.0 mmol) and phenylhydrazine 2a (1.0 mmol) in solvent (1.0 mL) was treated with additive followed by styrene 3 (1.0 mmol) and stirred.

Isolated yield; ND = not detected.

Scheme 1

Origin of regioselectivity in the formation of pyrazoline 4a.

A solution of tolualdehyde 1a (1.0 mmol) and phenylhydrazine 2a (1.0 mmol) in solvent (1.0 mL) was treated with additive followed by styrene 3 (1.0 mmol) and stirred. Isolated yield; ND = not detected. We have observed very good regioselectivity in the formation of pyrazolines mediated by TfOH. Mechanistically, the carbocation I-1 can interact with either of the alkenyl carbons in styrene resulting in two types of cationic intermediates: (i) the most stable benzylic carbocation I-2 and (ii) the least stable primary carbocation I-3. The stability of the benzylic carbocation I-2 over the primary carbocation I-3 directs the reaction pathway towards the formation of a 5-phenyl substituted product 4a over a 4-phenyl substituted product 5a (Scheme 1). The scope of this synthetic methodology has been studied by varying the substrates. Both aromatic and aliphatic aldehydes reacted well under the reaction conditions and their corresponding pyrazolines were obtained in yields of up to 86% (Table 2). The yields were in accordance with the stability of the corresponding benzylic cations I-1. In the reactions employing aromatic aldehydes with electron donating groups, pyrazolines were obtained in very good yields (Table 2, entries 1 and 2), as I-1 might receive additional stability from electron donating substituents. The methoxy group in the meta position did not play a considerable role in stabilizing the benzylic carbocation I-1, hence the yield of the corresponding pyrazoline 4c was moderate (Table 2, entry 3). Analogous to this, products were obtained in moderate yields for aldehydes with halogen substitution (Cl and Br) and without any substitution, as there is neutrality between the electron withdrawing effect through –I and the electron releasing effect through +R in H/Cl/Br– substituted aldehydes (2, entries 4–6). The high electronegativity of fluorine destabilizes I-1, hence its corresponding pyrazoline 4g was obtained in low yield (Table 2, entry 7). Similarly, pyrazolines 4h and 4i were obtained in poor yields due to the strong electron withdrawing effect of the –NO2 group via –I and –R (Table 2, entries 8 and 9). In every case, the obtained regioselectivity was very high and benzylic cation intermediate I-2 derived compounds were obtained as the only products.

Synthesis of various pyrazolines 4a–ma

EntryR =Ar =ProductYieldb (%)
14-Me–C6H4– 1aC6H5– 2a4a82
24-MeO–C6H4– 1bC6H5– 2a4b73
33-MeO–C6H4– 1cC6H5– 2a4c57
4C6H5– 1dC6H5– 2a4d63
54-Br–C6H4– 1eC6H5– 2a4e61
64-Cl–C6H4– 1fC6H5– 2a4f58
74-F–C6H4– 1gC6H5– 2a4g39
84-NO2–C6H4– 1hC6H5– 2a4h24
92-NO2–C6H4– 1iC6H5– 2a4i45
102-HO–C6H4– 1jC6H5– 2a4j82
11CH3CH2CH2– 1kC6H5– 2a4k86
12(CH3)2CH– 1lC6H5– 2a4l58
134-Me–C6H4– 1a4-Me–C6H4– 2b4m82

A solution of aldehyde 1a–l (1.0 mmol) and arylhydrazine 2a, 2b (1.0 mmol) in CH3CN (1.0 mL) was treated with TfOH followed by styrene 3 (1.0 mmol) and stirred.

Isolated yield.

A solution of aldehyde 1a–l (1.0 mmol) and arylhydrazine 2a, 2b (1.0 mmol) in CH3CN (1.0 mL) was treated with TfOH followed by styrene 3 (1.0 mmol) and stirred. Isolated yield. Using this methodology, we have attempted the synthesis of bis-pyrazoline 6 from terephthalaldehyde 1m. The bis-pyrazoline 6 was obtained in very low yield, which is also in accordance with the proposed mechanism depicted in Scheme 1. The formation bis-pyrazoline 6 was expected to proceed via a bis-benzylic cation I-4 (Scheme 2), which is highly destabilized by conjugation between two cationic sites. Thus, formation of the bis-benzylic cation I-4 is less probable and resulted in the observed poor yield of bis-pyrazoline 6 (18%) even after 48 h of reaction time. Bis-pyrazoline 6 was structurally characterized by NMR spectroscopy and high resolution mass spectrometry (HRMS) analysis.
Scheme 2

Synthesis of bis-pyrazoline 7 from terephthalaldehyde.

We wanted to apply this synthetic methodology in the synthesis of a pyrazoline alkaloid. Many species of the genus Euphorbia are medicinally important and known to treat various ailments including gonorrhea, skin diseases, gastrointestinal disorders, migraines and anaphylaxis.[38-41] Alkaloid 7 (1,5-diphenyl-3-styryl-2-pyrazoline) was isolated from aerial parts of Euphorbia guyoniana.[42] We have adopted TfOH mediated electrocyclization to access alkaloid 7 starting from cinnamaldehyde 1n, phenylhydrazine 2a and styrene 3. In this reaction, the formation of pyrazole 8via intramolecular electrocyclization is expected to compete with the formation of the desired alkaloid 7via intermolecular electrocyclization (Scheme 3). Interestingly, the reaction with cinnamaldehyde did not undergo intramolecular cyclization and the required alkaloid 7 was obtained in 82% yield.
Scheme 3

Application in alkaloid synthesis: synthesis of alkaloid 7.

Recently, deep eutectic solvents (DES) have been used as green solvents in various applications.[43-45] We have explored the use of a few DES including the eutectic mixture of (i) ChCl : urea, (ii) ChCl : PTSA, (iii) ChCl : TfOH and (iv) ChCl : glycol in our synthetic methodology to access trisubstituted pyrazolines (see ESI, Table S2†). The eutectic mixture ChCl : PTSA was found to be effective among the DES screened and corresponding 1,3,5-trisubstituted pyrazolines were obtained in yields of up to 61%, without the use of any additives (Table 3). We believe that the ChCl : PTSA DES itself can induce the formation of intermediate I-1 to some extent and can result in the formation of pyrazolines, even in the absence of catalysts.

Synthesis of various pyrazolines in DES mediaa

EntryR =Ar =ProductYieldb (%)
14-Me–C6H4– 1aC6H5– 2a4a45
22-HO–C6H4– 1jC6H5– 2a4j61
3CH3CH2CH2– 1kC6H5– 2a4k45
4C6H5–CH <svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="13.200000pt" height="16.000000pt" viewBox="0 0 13.200000 16.000000" preserveAspectRatio="xMidYMid meet"><metadata> Created by potrace 1.16, written by Peter Selinger 2001-2019 </metadata><g transform="translate(1.000000,15.000000) scale(0.017500,-0.017500)" fill="currentColor" stroke="none"><path d="M0 440 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z M0 280 l0 -40 320 0 320 0 0 40 0 40 -320 0 -320 0 0 -40z"/></g></svg> CH– 1n4-Me–C6H4– 2bAlkaloid 754

A mixture of aldehyde (1.0 mmol) arylhydrazine (1.0 mmol) and styrene (1 mmol) in DES (1.0 mL) stirred at 30 °C for 24 h.

Isolated yield.

A mixture of aldehyde (1.0 mmol) arylhydrazine (1.0 mmol) and styrene (1 mmol) in DES (1.0 mL) stirred at 30 °C for 24 h. Isolated yield. In conclusion, we have developed a metal free TfOH or DES mediated intermolecular electrocyclization of aldehydes, hydrazine and styrene to generate 1,3,5-trisubstituted pyrazolines. The observed very high regioselectivity of the reaction has been rationalized by the stability of the proposed benzylic cation intermediate. The substrate scope has been studied and various pyrazolines have been obtained in moderate to very good yields. The obtained yields were in accordance with the stability of the proposed intermediate carbocations obtained by the electronic effects of substitutions. Working towards greener synthesis, we have screened various deep eutectic mixtures as media for this transformation. The DES ChCl : PTSA was found to be effective in mediating pyrazoline formation and the corresponding pyrazolines were obtained in moderate yields in the absence of any other catalysts. The application of this synthetic methodology has been demonstrated in the synthesis of a natural product, alkaloid 7 obtained from aerial parts of Euphorbia guyoniana.

Conflicts of interest

There are no conflicts to declare.
  23 in total

1.  One-Pot Cascade Transformations of Zinc Trifluorodiazoethylide and α,β-Unsaturated Enones: Access to Trifluoromethylated Polycyclic Pyrazolines.

Authors:  Shuang Qin; Yan Zheng; Fa-Guang Zhang; Jun-An Ma
Journal:  Org Lett       Date:  2017-06-14       Impact factor: 6.005

2.  Dehydrogenation induced inhibition of intramolecular charge transfer in substituted pyrazoline analogues.

Authors:  Pronab Kundu; Dipanwita Banerjee; Gourhari Maiti; Nitin Chattopadhyay
Journal:  Phys Chem Chem Phys       Date:  2017-05-17       Impact factor: 3.676

3.  1,3-diketones from acid chlorides and ketones: a rapid and general one-pot synthesis of pyrazoles.

Authors:  Stephen T Heller; Swaminathan R Natarajan
Journal:  Org Lett       Date:  2006-06-22       Impact factor: 6.005

4.  Topical antiinflammatory effects of Euphorbia prostrata on carrageenan-induced footpad oedema in mice.

Authors:  A K Singla; K Pathak
Journal:  J Ethnopharmacol       Date:  1990-07       Impact factor: 4.360

5.  A new alkaloid and flavonoids from the aerial parts of Euphorbia guyoniana.

Authors:  Tarek Boudiar; Lakhal Hichem; A Khalfallah; Ahmed Kabouche; Zahia Kabouche; Igniacio Brouard; Jaime Bermejo; Christian Bruneau
Journal:  Nat Prod Commun       Date:  2010-01       Impact factor: 0.986

6.  The synthesis and angiotensin converting enzyme (ACE) inhibitory activity of chalcones and their pyrazole derivatives.

Authors:  Marco Bonesi; Monica R Loizzo; Giancarlo A Statti; Sylvie Michel; François Tillequin; Francesco Menichini
Journal:  Bioorg Med Chem Lett       Date:  2010-01-25       Impact factor: 2.823

7.  Reductive isoxazole ring opening of the anticoagulant razaxaban is the major metabolic clearance pathway in rats and dogs.

Authors:  Donglu Zhang; Nirmala Raghavan; Shiang-Yuan Chen; Haiying Zhang; Mimi Quan; Lloyd Lecureux; Laura M Patrone; Patrick Y S Lam; Samuel J Bonacorsi; Robert M Knabb; Gary L Skiles; Kan He
Journal:  Drug Metab Dispos       Date:  2007-11-05       Impact factor: 3.922

8.  Synthesis, antitubercular activity and docking study of novel cyclic azole substituted diphenyl ether derivatives.

Authors:  Suvarna G Kini; Anilchandra R Bhat; Byron Bryant; John S Williamson; Franck E Dayan
Journal:  Eur J Med Chem       Date:  2008-05-01       Impact factor: 6.514

9.  A novel methodology for synthesis of dihydropyrazole derivatives as potential anticancer agents.

Authors:  Xu Wang; Ying-Ming Pan; Xiao-Chao Huang; Zhong-Yuan Mao; Heng-Shan Wang
Journal:  Org Biomol Chem       Date:  2014-02-12       Impact factor: 3.876

Review 10.  Biological activities of pyrazoline derivatives--a recent development.

Authors:  Suresh Kumar; Sandhya Bawa; Sushma Drabu; Rajiv Kumar; Himanshu Gupta
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2009-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.